A realist review of medication optimisation of community dwelling service users with serious mental illness.

ABSTRACT:

Background

Severe mental illness (SMI) incorporates schizophrenia, bipolar disorder, non-organic psychosis, personality disorder or any other severe and enduring mental health illness. Medication, particularly antipsychotics and mood stabilisers are the main treatment options. Medication optimisation is a hallmark of medication safety, characterised by the use of collaborative, person-centred approaches. There is very little published research describing medication optimisation with people living with SMI.

Objective

Published literature and two stakeholder groups were employed to answer: What works for whom and in what circumstances to optimise medication use with people living with SMI in the community?

Methods

A five-stage realist review was co-conducted with a live

SUBMITTER: Howe J 

PROVIDER: S-EPMC11671929 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature